These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. In vivo base editing by a single i.v. vector injection for treatment of hemoglobinopathies. Li C; Georgakopoulou A; Newby GA; Everette KA; Nizamis E; Paschoudi K; Vlachaki E; Gil S; Anderson AK; Koob T; Huang L; Wang H; Kiem HP; Liu DR; Yannaki E; Lieber A JCI Insight; 2022 Oct; 7(19):. PubMed ID: 36006707 [TBL] [Abstract][Full Text] [Related]
13. Highly efficient editing of the β-globin gene in patient-derived hematopoietic stem and progenitor cells to treat sickle cell disease. Park SH; Lee CM; Dever DP; Davis TH; Camarena J; Srifa W; Zhang Y; Paikari A; Chang AK; Porteus MH; Sheehan VA; Bao G Nucleic Acids Res; 2019 Sep; 47(15):7955-7972. PubMed ID: 31147717 [TBL] [Abstract][Full Text] [Related]
14. Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells. DeWitt MA; Magis W; Bray NL; Wang T; Berman JR; Urbinati F; Heo SJ; Mitros T; Muñoz DP; Boffelli D; Kohn DB; Walters MC; Carroll D; Martin DI; Corn JE Sci Transl Med; 2016 Oct; 8(360):360ra134. PubMed ID: 27733558 [TBL] [Abstract][Full Text] [Related]
17. Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human β-globin locus. Antoniani C; Meneghini V; Lattanzi A; Felix T; Romano O; Magrin E; Weber L; Pavani G; El Hoss S; Kurita R; Nakamura Y; Cradick TJ; Lundberg AS; Porteus M; Amendola M; El Nemer W; Cavazzana M; Mavilio F; Miccio A Blood; 2018 Apr; 131(17):1960-1973. PubMed ID: 29519807 [TBL] [Abstract][Full Text] [Related]
18. Genome editing using CRISPR-Cas9 to create the HPFH genotype in HSPCs: An approach for treating sickle cell disease and β-thalassemia. Ye L; Wang J; Tan Y; Beyer AI; Xie F; Muench MO; Kan YW Proc Natl Acad Sci U S A; 2016 Sep; 113(38):10661-5. PubMed ID: 27601644 [TBL] [Abstract][Full Text] [Related]
19. Genome editing approaches to β-hemoglobinopathies. Brusson M; Miccio A Prog Mol Biol Transl Sci; 2021; 182():153-183. PubMed ID: 34175041 [TBL] [Abstract][Full Text] [Related]
20. Optimization of CRISPR/Cas9 Delivery to Human Hematopoietic Stem and Progenitor Cells for Therapeutic Genomic Rearrangements. Lattanzi A; Meneghini V; Pavani G; Amor F; Ramadier S; Felix T; Antoniani C; Masson C; Alibeu O; Lee C; Porteus MH; Bao G; Amendola M; Mavilio F; Miccio A Mol Ther; 2019 Jan; 27(1):137-150. PubMed ID: 30424953 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]